Aptensio Xr
Product Images NDC 42858-404

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Aptensio Xr (NDC 42858-404). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rhodes Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Aptensio 01

Chemical structure of the active ingredient shown for Aptensio XR, which is methylphenidate hydrochloride. The structure includes a phenyl ring, ester group, and a piperidine ring bonded to a methylated carbon with an attached hydrochloride ion.*

FDA Label Image

Aptensio 01a

A line graph depicting plasma concentrations (ng/mL) over 24 hours for APTENSIO XR 80 mg in two forms: capsule and sprinkle. The x-axis represents time in hours, and the y-axis shows plasma levels. Both forms exhibit similar concentration-time profiles with two peaks and gradual decline.*

FDA Label Image

Aptensio 02

A line graph comparing plasma concentrations (ng/mL) over time (hours) for APTENSIO XR 80 mg in capsule and sprinkle forms. The graph shows similar concentration profiles with peaks around 2 to 8 hours and a gradual decline up to 24 hours.*

FDA Label Image

Aptensio 03

A line graph comparing SKAMP Total Scores over time (hours) between placebo and Aptensio XR. The graph shows two lines: one with square markers representing placebo and another with triangle markers representing Aptensio XR, tracking score changes from 0 to 13 hours.*

FDA Label Image

Aptensio 04

Aptensio XR 10 mg extended-release capsules packaging label showing the product name, active ingredient (methylphenidate HCl), dosage strength (10 mg), dosage form (capsules), quantity (90 capsules), labeler (Rhodes Pharmaceuticals LLC), and storage instructions. The label also includes a warning to dispense the accompanying Medication Guide and indicates the product is Rx only.*

FDA Label Image

Aptensio 05

Label for Aptensio XR capsules, containing methylphenidate HCl extended-release, 15 mg strength. The label indicates a package size of 90 capsules and the drug is marked as Rx only. It is manufactured by Rhodes Pharmaceuticals LLC, with dosing instructions stating "Once Daily." The label includes a barcode, storage instructions, and a caution to dispense the accompanying medication guide to each patient.*

FDA Label Image

Aptensio 06

The label for Aptensio XR extended-release capsules contains methylphenidate HCl 20 mg. It is produced by Rhodes Pharmaceuticals LLC. The label shows the product name, strength, dosage form, and a 90 capsule count. It includes usage instructions to dispense the accompanying Medication Guide and states the drug is by prescription only.*

FDA Label Image

Aptensio 07

Label for Aptensio XR 30 mg extended-release capsules containing methylphenidate HCl. The label indicates the product is manufactured by Rhodes Pharmaceuticals LLC and distributed by Rhodes Technologies Inc. It includes dosage form, strength, quantity of 90 capsules, and usage instructions such as "once daily." The label also features warnings about use under medical supervision.*

FDA Label Image

Aptensio 08

Label for Aptensio XR 40 mg extended-release capsules (methylphenidate HCl) from Rhodes Pharmaceuticals LLC. The label includes dosage form, strength, prescription indication (Rx only), package count (90 capsules), storage instructions, and a note to dispense the accompanying Medication Guide. The design features the product name prominently along with manufacturer and FDA NDC number 42858-405-45.*

FDA Label Image

Aptensio 09

Aptensio XR 50 mg (methylphenidate HCl extended-release) capsules label from Rhodes Pharmaceuticals LLC. The label indicates the product is for Rx only, contains 90 capsules, and is intended for once daily use. It includes dosage and storage information along with a barcode and NDC number 42858-406-45.*

FDA Label Image

Aptensio 10

Aptensio XR 60 mg extended-release capsules label showing methylphenidate HCl as the active ingredient. The label indicates the product is manufactured by Rhodes Pharmaceuticals LLC and distributed by Marathon Pharmaceuticals. It contains 90 capsules with a recommended once-daily dosage. The label includes a notice to dispense the accompanying Medication Guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.